420 with CNW — New Report Projects Annual Tax Earnings of $375M If Ohio Legalizes Marijuana

According to research coming out of Ohio State University, Ohio stands to earn about $375 million tax revenue each year if the state legalizes recreational marijuana. This study, whose findings were published in time for the unofficial 4/20 marijuana holiday, relied on estimates of possible taxes to be levied if the legalization proposal is adopted as-is.

The team of researchers looked at the estimated population growth rate and annual tax revenue from half a dozen states with adult-use cannabis markets. The states looked at included Nevada, Michigan, Illinois, Colorado, Washington and Oregon. The team also analyzed the proposed taxes included in the draft legalization measure. Based on this data, they came up with projections detailing how much Ohio could earn as tax revenue when the marijuana market matures.

Depending on how optimistic one is when predicting the growth trajectory of the Ohio adult-use recreational cannabis market, anticipated taxes could be anywhere between $276 million and $375 million each year by the time the industry reaches its fifth year of existence. Compared to the annual state budget amounting to approximately $60 billion, this tax would be a tiny drop in the funding basket of Ohio.

The researchers also note that their study had a number of limitations based on assumptions such as prices, the roll out of the market, regulatory challenges and marijuana consumption patterns as well changes in the tax structure. Any of these factors could alter the market and the subsequent taxes generated, the team notes.

It isn’t also clear whether the proposal to legalize adult-use cannabis will be passed by the lawmakers. They are being forced to consider the initiative after advocates collected a total of 133,000 voter signatures. If the legislature refuses to endorse the proposal, the campaigners will have no choice but to gather the same number of voter signatures in order to put the issue before voters during this year’s ballot.

Taking the matter to voters is looking increasingly likely given that previous endeavors to enact marijuana reform through legislative means have been futile. Leading Republicans in the state legislature have even signaled that they will not support the push to legalize recreational marijuana in the state, so it is likely to be an uphill task for this proposal to gain legislative approval.

When this process ends in an enabling law being passed, Ohio could open its doors to licensed companies such as American Cannabis Partners and begin reaping tax revenue and other economic benefits in the way other states with regulated markets are doing.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Hero Technologies Inc. (HENC) Focused on Vertical Integration, State Expansion

Hero Technologies (OTC: HENC), a cannabis company working toward a vertically integrated business model, has plans to expand into two states that have legalized cannabis — Colorado and Massachusetts. Cannabis genetic engineering, farmland for medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, retail operations and dispensaries are all part of HENC’s strategic multistate model. The company owns a majority stake in BlackBox Systems and Technologies LLC. BlackBox is an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. A recent article discussing the company’s growth plans reads, “HENC’s Colorado expansion will come through its wholly owned subsidiary Mile High Green LLC, while expansion in Massachusetts is planned through another wholly owned subsidiary, MassCannabis LLC.”

To view the full article, visit https://cnw.fm/NymGn

About Hero Technologies Inc.

Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions and increased harvest efficiencies. Hero Technologies’ strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multi-state operator (“MSO”). For more information about the company, visit www.HeroTechnologiesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://cnw.fm/HENC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – American Cannabis Partners Leveraging Focus on Key Business Segments to Capture Opportunity

American Cannabis Partners (“ACP”), a sustainable Jamaican experience canna-business innovator, currently operates in Michigan and California and is also in the process of exploring land acquisition and project development strategies for expanding operations to two more states this year. “With a total of 12 cannabis licenses, including 560,000 square feet of cultivation licenses in California and Michigan and one retail license in Michigan, ACP is committed to becoming a leader in the U.S. cannabis industry,” reads a recent article discussing the company. “ACP is focused on multiple business segments: real estate, acquisition and development of proprietary assets, and ongoing cultivation operations. Led by a seasoned management team with more than three decades of canna-business experience, ACP is guided by its strategy to capture opportunities in real estate and licensing in states that have recently passed cannabis legalization legislation, thereby equipping the company to capitalize on federal interstate commerce opportunities… Through its current cultivation operations, ACP supplies approximately 80% of its whole flower products for manufacturing, distribution and retail licenses. With the remaining 20%, the company supplies its proprietary strains to select California distributors and its own Michigan retail location under its exclusive in-house brand, ZÜK.”

To view the full article, visit https://cnw.fm/8fC83

About American Cannabis Partners

American Cannabis Partners is a fully licensed, large scale and 100% organic cannabis cultivation company nationally headquartered in Trinity County of the Emerald Triangle. Guided by business professionals and cultivators, the company focuses on four industry segments: real estate, cultivation, medical research, and nonprofit groups. For both medical and recreational, American Cannabis Partners supplies multiple forms of raw product at wholesale prices for manufacturing, distribution and retail licenses. Its commodity pricing model enables stable profit margins for customers, aiding the company’s expansion into multiple states. For more information, visit the company’s website at www.ACPFarms.com.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Vantage Hemp Company Announces Submission of DMF, Reinforces Commitment to Deliver Superior API Quality

Vantage Hemp has submitted a Drug Master File (“DMF”) to the U.S. Food & Drug Administration (“FDA”) covering its hemp-derived cannabidiol (“CBD”) distillate. According to the announcement, the submission further reinforces Vantage as a transparent, reliable and compliant partner, committed to working with pharmaceutical companies to formulate its CBD active pharmaceutical ingredient (“API”). The filing, which also strengthens Vantage’s position as an industry leader, represents the company’s commitment to support its clients through all phases of drug development. The company also noted that it anticipates filing future DMF submissions as it works to deliver superior API quality. “Our distillate DMF filing is a testament to Vantage’s dedication to manufacturing the highest-quality CBD API,” said Vantage’s Chief Operating Officer Deepank Utkhede in the press release. “Vantage exemplifies the breadth of knowledge, depth of collaboration, and attention to detail expected and required of an API producer.”

To view the full press release, visit https://cnw.fm/yIJMq

About Vantage Hemp Co.

With large-scale extraction facilities, Colorado-based Vantage Hemp delivers pharmaceutical-grade GMP-compliant CBD extracts, including full-spectrum oil, distillate, and isolate, that companies can trust. Vantage’s contract manufacturing services offer a broad range of benefits as the company operates with integrity and abides by stringent pharmaceutical-production standards to provide quality products to its partners. For more information about the company, please visit www.VantageHemp.com

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Participate in Luxury Meets Cannabis Conference

Flora Growth’s (NASDAQ: FLGC) executives Luis Merchan and James Choe are scheduled to participate at the upcoming Luxury Meets Cannabis Conference. The two-day event is scheduled for May 5–6, 2022, in New York City. The premier B2B CBD, hemp and cannabis event — the first of its kind — is an ideal venue to shine a spotlight on FLGC’s impressive line of lifestyle products and brands. The conference is designed to bring together premium CBD, hemp and cannabis brands and their founders with representatives from top mainstream retailers, global media, leading dispensaries and investors. Flora Growth is a leading all-outdoor cannabis cultivator and manufacturer. Flora Growth CEO Merchan will be involved in the first offering of the conference, the Business Insider Live at LMCC 2022: New York Is Ready for Youevent hosted by Business Insider’s Yeji Jesse Lee and Jeremy Berke. Choe, the company’s chief strategy officer, will participate in a panel scheduled for the second day of the conference. Panel members are slated to discuss essential insights into the voice of the cannabis consumer. “We are looking forward to sharing our excitement for the global opportunity of CBD, hemp and cannabis with other business leaders and industry experts at the Luxury Meets Cannabis Conference in New York,” said Flora Growth CEO Luis Merchan in the press release. “We’re continuing to execute on our strategy to build a global house of brands servicing consumers across the globe, and firmly believe the future of cannabis has a meaningful place in the luxury retail market.”

To view the full press release, visit https://cnw.fm/GMmjm 

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands designed to deliver the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective farming practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Extends Michigan Expansion with Debut of Platinum Vape Live Resin; Announces Plans to Release Full-Year 2021 Results on May 2

  • Red White & Bloom and its wholly owned subsidiary RWB Michigan LLC recently announced the rollout of Platinum Vape(TM) Live Resin in Michigan
  • The debut marks the company’s entry into the live resin in Michigan, which yield higher margins than the company’s existing distillate vape products
  • RWB expects to release its full-year 2021 results on May 2, with the management hosting a conference call on May 3

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator on a mission to become the most recognizable cannabis company in the United States, is celebrating the fulfillment of its promise to consumers to introduce a steady stream of new products and consumption options to satisfy demand in Michigan, recently announcing it will roll out the Platinum Vape(TM) (“PV”) Live Resin in Michigan. The company, working in conjunction with its wholly owned subsidiary RWB Michigan LLC, will make the product available in nearly 400 Michigan dispensaries in due course (https://cnw.fm/Au7WC).

The debut marks RWB’s line expansion into the higher-margin Live Resin Vapes segment and also represents its inaugural product in Michigan beyond the popular distillate vape products. The company is committed to releasing many more products in the future. 

The PV Live Resin delivers a lush flavor profile and rich potency experience, thanks to its ability to capture and preserve the terpenes and trichomes of RWB’s premium cannabis strains. (Live resin is a cannabis concentrate created using fresh flower.) A compact product with a myriad of consumption options, the PV Live Resin packs all the benefits of the cannabis flower and more than 80 cannabinoids that synergistically work to enhance the plant’s therapeutic properties.

Red White & Bloom expects PV Live Resin to become popular with consumers owing to the trust they have in the PV brand. With the PV Live Resin, which was previously only available in Oklahoma and California, RWB aims to tap into the growing U.S. live resin market. According to Greentank, live resin sales increased 86% between 2020 and 2021 (https://cnw.fm/l5Gzn). But RWB holds that this growth is only the tip of the iceberg. 

“We believe that this is just the tip of the iceberg for the live resin opportunity since so many new cannabis consumers are totally unfamiliar with live resin and migrate to it once they learn more about cannabis and discover live resins’ many advantages,” company CEO Brad Rogers said.

Red White & Bloom is simultaneously streamlining its seed-to-sale processes and speeding up the development and go-to-market timelines for new products. According to Rogers, the company has already started expanding the distribution of its PV branded products, including the new PV Live Resin line, with the PV products now available in nearly 400 of Michigan’s 460+ dispensaries. 

Meanwhile, the company announced it will release its end-year (2021) financial results, subsequent events, and management discussion and analysis (“MD&A”) on Monday, May 2, after markets close. The following day, Tuesday, May 3, company Rogers will host a conference call in which he will discuss RWB’s quarterly results, operations, and upcoming events. Rogers will also join the management team in fielding questions from stakeholders and investors (https://cnw.fm/tNKD1).

The 2021 results will draw the curtains on an eventful year that saw the company report $11.8 million in revenue in Q1 2021 and $13.3 million in Q2 2021 (https://cnw.fm/TXgYP). In Q3 2021, Red White & Bloom’s revenue was up 93% year-over-year to $11.8 million from $6.1 million in Q3 2020 (https://cnw.fm/3DiWz). Already, the company’s cumulative revenue from the first nine months of the 2021 fiscal year (~$36.9 million) has surpassed the full year 2020 revenue ($23.3 million) (https://cnw.fm/xg4ir), setting the stage for what is likely to be a record-breaking year for Red White & Bloom.

The 2021 financial year also saw the announcement of key milestones, including the acquisition of cultivation facilities in Apopka, Florida and Sanderson, Florida; the opening of a production facility at the Sanderson property; receipt of Adult Use prequalification status in Michigan and approval from the Florida Department of Health, Office of Medical Marijuana Use; and more.

For more information, visit the company’s website at www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands its Patent Portfolio With New Patent for Antiviral Drug Delivery with DehydraTECH

  • Lexaria just received another patent for DehydraTECH(TM): this time for the enhanced delivery of antiviral drugs
  • This becomes the company’s 25th patent granted worldwide and the 10th granted in the U.S.
  • It adds to the company’s growing patent portfolio, which also consists of ~50 pending patents worldwide
  • Over the 2022 calendar year, the company seeks to also pursue regulatory and commercial advancement

In 2016, Lexaria Bioscience (NASDAQ: LEXX) received its first United States patent grant and over the years, the company has been aggressive at broadening its patent suite, a move which it has attributed to refining the patent claims via further US provisional and utility patent filings. More patents mean more intellectual property and enhanced ability to pursue regulatory and commercial progress.

As of March 2022, Lexaria had 24 patents, having been granted its latest one in Australia, titled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof” (https://cnw.fm/dT7sy). 

In what marks another significant milestone for Lexaria, it has announced receiving its first-ever patent for the use of DehydraTECH(TM) technology in the enhanced delivery of antiviral drugs. Patent 11,311,559, titled “Compositions and Methods for Enhanced Delivery of Antiviral Agents,” becomes the 10th granted in the U.S. 

“This will be our 25th patent granted worldwide and another validation of the versatility of our DehydraTECH drug delivery technology,” noted Lexaria’s Chief Executive Officer (“CEO”), Chris Bunka (https://cnw.fm/lChJc). 

Lexaria had earlier announced and demonstrated how effective remdesivir and ebastine processed with DehydraTECH were against inhibiting COVID-19/SARS-CoV-2. It also separately proved that antiviral drugs processed with DehydraTECH reached peak blood concentration levels that were double those of non-DehydraTECH-processed alternatives. In addition, the company showed that the overall volumes of drugs delivered into the bloodstream were up to triple that of non-DehydraTECH-processed variants.

Lexaria remains focused on exploring DehydraTECH’s full potential. So far, it is exploring its potential usage in treating heart disease and hypertension. It is also separately conducting studies on oral nicotine delivery, antiviral delivery, epilepsy, hormone replacement, rheumatoid disease, dementia, and diabetes, most of which will define clinical studies for the 2022 calendar year and beyond.

The company’s management has even noted that the company will continue to see significant milestones in using DehydraTECH, specifically DehydraTECH-CBD, for potential hypertension and heart disease treatment, among other conditions.

“We are delighted to announce that DehydraTECH as an enhanced drug delivery platform will also be evaluated for characteristics and potential treatment options for hormone replacement, dementia, rheumatoid disease, and diabetes,” noted Mr. Bunka back in February (https://cnw.fm/8ztYq). 

Most notably, Lexaria’s management reckons that clinical studies for 2022 are on schedule and will play an integral role in receiving even more patents for its DehydraTECH technology.

“The approval (by the independent review board earlier this year) sets the stage for the HYPER-H21-4 study that could define Lexaria’s future. DEM-A22-1, expected to begin in July 2022, will evaluate DehydraTECH-CBD with or without nicotine for the potential treatment of dementia. Lexaria also plans to execute on the RHEUM-A22-1 and DIAB-A22-1 studies, scheduled for October and November, respectively…” said Mr. Bunka.

In addition to the 25 granted patents, Lexaria has over 50 pending patents worldwide and is committed to growing its patent portfolio for the benefit of its shareholders, clients, and patients dealing with various conditions that could benefit from its DehydraTECH technology.

“This new patent adds to our existing suite of granted patents in the EU, the U.S., India, Japan, and Australia, and continues to build value for Lexaria shareholders and clients,” Bunka noted.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Bipartisan State AGs Send Letter to Senate Leaders Demanding Cannabis Banking Law

A bipartisan pair of attorneys general from Ohio and Colorado recently penned a letter to the leaders of the U.S. Senate urging the chamber to quickly pass a bill protecting financial institutions that accept marijuana businesses as clients in states that have regulated marijuana markets.

This letter from Ohio AG Dave Yost and Colorado AG Philip Weiser is the latest in a series of communications imploring legislators to expeditiously pass the SAFE Banking Act, which seems to be caught in a vicious cycle of being passed by the House of Representatives and then stalling in the Senate.

The two attorneys general, who also double as cochairs of an influential committee of the association bringing together all attorneys general across the country, revealed in their recent letter that all states with marijuana markets share a strong interest with the federal government to protect public safety in addition to bringing financial activities in legal grey areas into the formal banking system. They therefore implore the Senate to enact cannabis banking legislation so that the common interests of the federal government and states can be attained.

The bill at the center of this pressure is the SAFE Banking Act authored by Rep. Ed Perlmutter, a Democrat from Colorado. The bill seeks to shield any bank working with state-legal marijuana firms from federal sanctions given that marijuana is still illegal at the federal level.

This letter comes at the time when officials in Washington State are faced with an upsurge of robberies and other criminal activities targeting marijuana businesses in the state. These officials are demanding federal action on cannabis banking, and they also plan to explore their own options of protecting banks while the federal administration remains silent on this matter.

It is baffling how Democrats who control the House of Representatives, the Senate and White House, can fail to approve this banking reform measure. One possible explanation is the opposition of Chuck Schumer, the Senate Majority Leader, to any cannabis policy reforms that don’t address reforms to the criminal justice system, address social equity matters, and decriminalize or legalize marijuana. He thinks that passing the banking reform bill is giving big businesses what they want without addressing the concerns of the general population.

Schumer is working on tabling a long-awaited cannabis legalization bill that was initially scheduled to be filed by the end of this month, but the Senate Majority Leader announced that he would delay the filling of this bill while more consultations take place to garner consensus and increase the odds of a successful outcome.

The federal legalization of marijuana would allow established companies such as Flora Growth Corp. (NASDAQ: FLGC) to expand quickly across the country and serve a lot more people with their skin-care, pharmaceuticals and wellness products, in addition to serving the international market.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — How No-Till Cultivation Can Be Beneficial to Marijuana Growers

There is an emerging trend in which marijuana growers are switching to techniques that involve the use of living soil, such as the no-till method, to grow their crops. This method is increasing in popularity because of its beneficial effects on the environment, its ability to reduce grower costs and its positive effects on the quality of the marijuana harvested at the end of the grow cycle.

In this system, the soil isn’t cultivated as is usually the case in conventional agriculture. Instead, mulch and cover crops are used to provide an enabling environment for the robust proliferation of microorganisms, which break down nutrients and make them available to the marijuana plants. For example, networks of fungus can break down minerals contained in the rocks within the soil so that marijuana roots can absorb them for use by a grower’s plants.

By doing away with topsoil tilling, cannabis growers eliminate the need to purchase costly cultivation equipment and instead rely on simple hand tools. Additionally, there is hardly a need to apply synthetic fertilizers, especially after a few years when the soil is now healthy and can avail all the nutrients marijuana plants need on a continuous basis.

Talk about the commercial cultivation of marijuana and many people will immediately think about how much water the system guzzles on a daily basis. With no-till cultivation, water use is minimized since the living soil with its plentiful organic matter retains water more effectively than soil that is cultivated in the conventional way. The mulch covering the soil prevents evaporation since the soil is shielded from the harsh rays of the sun.

Josh Turner, Massachusetts-based Green Meadow’s VP in charge of cultivation, says that no-till systems yield marijuana with a higher potency and a richer terpene profile. This makes sense given that the microorganisms in the soil make various nutrients from rocks, plant debris and soil available to marijuana plants, thereby enabling the cannabis to be of a high quality.

However, cannabis growers planning to switch to the no-till system need to be patient because it takes several years for living soil to establish itself. Additionally, the initial stages of this method are costly. However, once the living soil reaches a point when it is self-sustaining, those initial costs can be recovered over the subsequent years when input is minimal.

An inevitable consequence of creating a rich living soil is that weeds will compete with marijuana plants due to the presence of rich nutrients in the soil. To manage these weeds, mulch the cultivation beds and rotate the cover crops so that weed development is stifled.

As inflation soars and the population becomes more picky about where they spend their money, cannabis sector players such as Cannabis Strategic Ventures Inc. (OTC: NUGS) are having to get very creative so that their products remain competitively priced in order to maintain or even grow their market share in the jurisdictions where they operate. No-till farming is one of the cost-cutting options on the table.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Unlock Capabilities of Revolutionary DehydraTECH(TM) Platform

Lexaria Bioscience Corp. (NASDAQ: LEXX) is aware of the need to continuously improve its understanding of the capabilities and potential applications of its patented DehydraTECH(TM) drug delivery technology. This informs its long-held commitment to its applied research and development (“R&D”) programs. “So far, the company’s research journey has involved a series of controlled and well-designed in vitro preclinical testing and in vivo animal and human clinical studies…. Still, Lexaria is unrelenting in its pursuit of comprehensive datasets that would answer many questions the company expects to face from potential commercial partners or regulators and is, in fact, expanding its research. [In March], Lexaria kicked off an animal study to evaluate DehydraTECH-CBD as a potential treatment to inhibit seizure activity, the first in a series of additional planned animal studies tentatively set to commence this year,” a recent article reads. “‘DehydraTECH is not an EVOLUTION of existing technology – it is a REVOLUTIONARY new drug delivery platform. Expecting entire industries to change overnight to adopt a revolutionary process is not realistic: it takes time, evidence, and a lot of positive results to overcome industry inertia. We have long been hopeful that, before the end of 2022, we will have built sufficient data to effect meaningful industry and/or regulatory progress and sustainable increases in valuation,’ Lexaria CEO Chris Bunka wrote in a recent letter to shareholders.”

To view the full article, visit https://cnw.fm/dHpXY

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by up to 5-10x, reduce time of onset from 1 – 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 25 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.